Taniesh Amon, PSYD in Anchorage, AK - Clinical Neuropsychologist

Taniesh Amon, PSYD is a Clinical Neuropsychologist based in Anchorage, Alaska. Taniesh Amon is licensed to practice in Alaska (license number 184612) and her current practice location is 4441 Diplomacy Dr, Anchorage, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 729-8880.

NPI number for Taniesh Amon is 1396490405 and her current mailing address is 4441 Diplomacy Dr, Anchorage, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1396490405.

Contact Information

	Taniesh Amon, PSYD
	4441 Diplomacy Dr, Anchorage, AK 99508-5910
	(907) 729-8880
	Not Available

Healthcare Provider's Profile

Full Name	Taniesh Amon
Gender	Female
Speciality	Clinical Neuropsychologist
Location	4441 Diplomacy Dr, Anchorage, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1396490405
Provider Enumeration Date: 02/16/2022
Last Update Date: 04/13/2023

Medical Identifiers

Medical identifiers for Taniesh Amon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396490405	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TC2200X	Psychologist - Clinical Child & Adolescent	184612 (Alaska)	Secondary
103G00000X	Clinical Neuropsychologist	184612 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Taniesh Amon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Taniesh Amon, PSYD 4441 Diplomacy Dr, Anchorage, AK 99508-5910 Ph: (907) 729-8880	Taniesh Amon, PSYD 4441 Diplomacy Dr, Anchorage, AK 99508-5910 Ph: (907) 729-8880

News Archive

Narcotic drug use should be treated as illness, U.N. drug office director says

"Prevention, treatment, rehabilitation, reintegration and health have to be recognized as key elements in our strategy" to fight drug demand, supply and trafficking, U.N. Office on Drugs and Crime Executive Director Yuri Fedotov said Monday at the opening session of the U.N. Commission on Narcotic Drugs in Vienna, United Press International reports.

Research finds evidence linking number of ribosomal genes to bacterial growth rate and efficiency

Microbes that can reproduce rapidly in times of plenty have an evolutionary stockpile of extra genes that allows them to quickly respond to changing conditions such as oil spills or outbreaks of intestinal diseases.

Borrelia infection can cause scleratrophic skin lesions in certain countries

This review summarizes the literature on scleratrophic skin lesions as a manifestation of a Borrelia infection. An association of morphea with Lyme borreliosis LB was mainly reported from Middle-European Countries, Japan and South America. B. afzelii has been identified predominantly from the chronic skin lesions of acrodermatitis chronica atrophicans (ACA) and has been cultivated from morphea lesions in isolated cases.

IQ Therapeutics achieves 100% survival in rabbit model at 48 hours after inhalation anthrax infection

IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.

Taniesh Amon, PSYD - in Anchorage, AK